Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in MRK — Merck & Co., Inc.

CIK 1000275 TORONTO, A6
Back to MRK Full portfolio

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,836,661,547
+$248,626,414 QoQ
Shares Held
14,293,086
+8.3% QoQ
Ownership
0.579%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#25
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Jun 30, 2026
CallValue
$83,525,000
CallShares
650,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $19,128,320,487 across 19 Drug Manufacturers - General names. MRK ranks #5 (9.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 4,358,401 $5,227,597,337
2 JNJ
Johnson & Johnson
 13,211,475 $3,355,318,297
3 ABBV
AbbVie Inc.
 8,163,806 $2,054,340,133
4 AZN
Astrazeneca PLC
 10,427,503 $1,977,263,112
5 MRK
Merck & Co., Inc.
This page 		14,293,086 $1,836,661,547
6 AMGN
Amgen Inc
 4,328,785 $1,567,539,618
7 PFE
Pfizer Inc
 32,814,260 $790,167,373
8 BMY
Bristol Myers Squibb Co
 12,094,886 $696,907,326

All Filings in MRK

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,836,661,547 14,293,086
2026-06-30 $83,525,000 650,000
2026-03-31 $1,588,035,133 13,201,722
2026-03-31 $18,043,500 150,000
2025-12-31 $1,388,388,340 13,190,085
2025-09-30 $1,075,004,221 12,808,343
2025-06-30 $27,706,000 350,000
2025-06-30 $1,072,866,556 13,553,140
2025-03-31 $42,636,000 475,000
2025-03-31 $1,272,630,644 14,178,149
2024-12-31 $1,828,041,886 18,375,974
2024-09-30 $1,882,104,934 16,573,661
2024-09-30 $6,813,600 60,000
2024-06-30 $1,942,799,089 15,693,046
2024-03-31 $1,788,602,167 13,555,151
2023-12-31 $1,632,255,500 14,972,074
2023-09-30 $1,366,756,265 13,275,923
2023-06-30 $17,308,500 150,000
2023-06-30 $1,668,500,852 14,459,666
2023-03-31 $63,834 600
2023-03-31 $24,384,588 229,200
2023-03-31 $1,588,604,196 14,931,894
2022-12-31 $1,733,273,096 15,622,110
2022-12-31 $53,799,655 484,900
2022-12-31 $50,826,195 458,100
2022-09-30 $1,478,243,936 17,164,932
2022-09-30 $24,113,600 280,000
2022-09-30 $6,915,436 80,300
2022-06-30 $6,928,920 76,000
2022-06-30 $40,907,979 448,700
2022-06-30 $1,596,806,166 17,514,601
2022-03-31 $1,399,380,135 17,055,212
2022-03-31 $4,717,875 57,500
2022-03-31 $6,235,800 76,000
2021-12-31 $10,806,240 141,000
2021-12-31 $1,283,927,071 16,752,702
2021-12-31 $9,518,688 124,200
2021-09-30 $9,388,750 125,000
2021-09-30 $1,001,280,662 13,330,857
2021-09-30 $9,013,200 120,000
2021-06-30 $3,499,650 45,000
2021-06-30 $1,043,949,242 13,423,547
2021-03-31 $1,184,252,276 15,361,936
2021-03-31 $20,621,586 267,500
2021-03-31 $770,900 10,000
2020-12-31 $34,118,764 417,100
2020-12-31 $1,749,082,796 21,382,440
2020-12-31 $65,947,130 806,200
2020-09-30 $3,060,856 36,900
2020-09-30 $1,700,163,887 20,496,240

Report a Problem

Category
Description
Email (optional, for follow-up)